ENHANCED LYTIC EFFICACY OF MULTIPLE BOLUS INJECTIONS OF TISSUE PLASMINOGEN-ACTIVATOR IN DOGS

被引:7
|
作者
KLABUNDE, RE [1 ]
BURKE, SE [1 ]
HENKIN, J [1 ]
机构
[1] ABBOTT LABS,DEPT THROMBOLYT VENTURE D48R,ABBOTT PK,IL 60064
关键词
Alpha-2-Antiplasmin; Clot Lysis; Fibrinogen; Fibrinolysis; Thrombolysis; Tissue Plasminogen Activator;
D O I
10.1016/0049-3848(91)90256-V
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The purpose of this study was to compare the lytic efficacy of tissue plasminogen activator (tPA) following different dosing regimens. Radiolabelled clots from dog whole blood were inserted into an extracorporeal jugular loop in anesthetized dogs. Clot size (counts/min) was continuously recorded, tPA was administered as a single 1 min bolus of 0.4 mg/kg, as four multiple bolus injections of 0.1 mg/kg each at 30 min intervals, or as an initial bolus (0.04 mg/kg) followed by a 30 min infusion of 0.36 mg/kg (10%/90%, bolus/infusion). Multiple injections of the same total dose of tPA resulted in 76% and 51% greater clot lysis than single bolus injection or bolus/infusion regimen, respectively, measured 120 min after initial dosing. There were no differences in fibrinogen, plasminogen or alpha-2-antiplasmin between the different treatment groups at 120 min. © 1990.
引用
收藏
页码:511 / 517
页数:7
相关论文
共 50 条
  • [1] THROMBOLYSIS WITH BOLUS INJECTIONS AND INFUSIONS OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR IN RABBITS WITH EXPERIMENTAL JUGULAR-VEIN THROMBOSIS
    STASSEN, JM
    LIJNEN, HR
    VANLINTHOUT, I
    COLLEN, D
    FIBRINOLYSIS, 1991, 5 (03) : 165 - 170
  • [2] TISSUE PLASMINOGEN-ACTIVATOR TREATMENT OF EXPERIMENTAL SUBRETINAL HEMORRHAGE
    JOHNSON, MW
    OLSEN, KR
    HERNANDEZ, E
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 1991, 11 (02): : 250 - 258
  • [3] CORONARY THROMBOLYSIS WITH DESMODUS SALIVARY PLASMINOGEN-ACTIVATOR IN DOGS - FAST AND PERSISTENT RECANALIZATION BY INTRAVENOUS BOLUS ADMINISTRATION
    WITT, W
    MAASS, B
    BALDUS, B
    HILDEBRAND, M
    DONNER, P
    SCHLEUNING, WD
    CIRCULATION, 1994, 90 (01) : 421 - 426
  • [4] CIRCADIAN VARIATION IN THE EFFICACY OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR
    KURNIK, PB
    CIRCULATION, 1995, 91 (05) : 1341 - 1346
  • [5] TISSUE PLASMINOGEN-ACTIVATOR AND PLASMINOGEN-ACTIVATOR INHIBITOR IN PATIENTS WITH LIVER-CIRRHOSIS
    LASIERRA, J
    AZA, MJ
    VILADES, E
    POBLET, S
    BARRAO, F
    BAYON, E
    GONZALEZ, J
    FIBRINOLYSIS, 1991, 5 (02) : 117 - 120
  • [6] TISSUE PLASMINOGEN-ACTIVATOR IN PERIPHERAL ARTERIAL THROMBOLYSIS
    BERRIDGE, DC
    GREGSON, RHS
    MAKIN, GS
    HOPKINSON, BR
    BRITISH JOURNAL OF SURGERY, 1990, 77 (02) : 179 - 182
  • [7] LIPOPROTEIN(A) INHIBITION OF PLASMINOGEN ACTIVATION BY TISSUE-TYPE PLASMINOGEN-ACTIVATOR
    EDELBERG, JM
    GONZALEZGRONOW, M
    PIZZO, SV
    THROMBOSIS RESEARCH, 1990, 57 (01) : 155 - 162
  • [8] EFFICACY OF TISSUE PLASMINOGEN-ACTIVATOR IN THE LYSIS OF THROMBOSIS OF THE CEREBRAL VENOUS SINUS
    ALEXANDER, LF
    YAMAMOTO, Y
    AYOUBI, S
    ALMEFTY, O
    SMITH, RR
    NEUROSURGERY, 1990, 26 (04) : 559 - 564
  • [9] ENHANCED LEVELS OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR IN BORDERLINE HYPERTENSION
    WALL, U
    JERN, C
    BERGBRANT, A
    JERN, S
    HYPERTENSION, 1995, 26 (05) : 796 - 800
  • [10] COMPARISON OF UROKINASE AND TISSUE PLASMINOGEN-ACTIVATOR FOR THROMBOLYSIS IN RATS
    MAGINOT, TJ
    SADOVE, AM
    JONES, C
    INVESTIGATIVE RADIOLOGY, 1991, 26 (01) : 46 - 49